Databases & Libraries Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database
Conditions: Cancer; Immune-related Adverse Event; Immune Checkpoint Inhibitor-Related Myocarditis Intervention: Drug: Immune checkpoint inhibitor Sponsors: Groupe Hospitalier Pitie-Salpetriere; Institut Curie Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions: Telangiectasia, Hereditary Hemorrhagic; Intracranial Arteriovenous Malformations Intervention: Other: Brain MRI Sponsor: Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Condition: Major Depressive Disorder Interventions: Drug: Vortioxetine Tablet; Drug: SSRI Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database
Conditions: Cancer; Immune-related Adverse Event; Immune Checkpoint Inhibitor-Related Myocarditis Intervention: Drug: Immune checkpoint inhibitor Sponsors: Groupe Hospitalier Pitie-Salpetriere; Institut Curie Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions: Telangiectasia, Hereditary Hemorrhagic; Intracranial Arteriovenous Malformations Intervention: Other: Brain MRI Sponsor: Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Condition: Major Depressive Disorder Interventions: Drug: Vortioxetine Tablet; Drug: SSRI Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions: Telangiectasia, Hereditary Hemorrhagic; Intracranial Arteriovenous Malformations Intervention: Other: Brain MRI Sponsor: Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database
Conditions: Cancer; Immune-related Adverse Event; Immune Checkpoint Inhibitor-Related Myocarditis Intervention: Drug: Immune checkpoint inhibitor Sponsors: Groupe Hospitalier Pitie-Salpetriere; Institut Curie Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions: Telangiectasia, Hereditary Hemorrhagic; Intracranial Arteriovenous Malformations Intervention: Other: Brain MRI Sponsor: Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression
Condition: Major Depressive Disorder Interventions: Drug: Vortioxetine Tablet; Drug: SSRI Sponsor: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database
Conditions: Cancer; Immune-related Adverse Event; Immune Checkpoint Inhibitor-Related Myocarditis Intervention: Drug: Immune checkpoint inhibitor Sponsors: Groupe Hospitalier Pitie-Salpetriere; Institut Curie Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
Conditions: Telangiectasia, Hereditary Hemorrhagic; Intracranial Arteriovenous Malformations Intervention: Other: Brain MRI Sponsor: Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials